Cibc Private Wealth Group, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,000 shares of ARWR stock, worth $39,610. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,000
-0.0%
Holding current value
$39,610
Previous $18,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ARWR
# of Institutions
332Shares Held
99.7MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$621 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$615 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$420 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$252 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$207 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $4.19B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...